Report: Lilly offers $6.1B for ImClone
Eli Lilly and Co. is in late talks to acquire ImClone Systems Inc. for $6.1 billion, according to a report on The Wall Street Journal’s Web site. The New York biotech firm develops various medicines for cancer treatments. Lilly would pay $70 per share for ImClone, the Journal said. The deal would be one of […]